Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.52 USD | +2.63% | +2.93% | +71.50% |
04-01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
04-01 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.50% | 388M | |
+2.47% | 108B | |
+9.65% | 105B | |
+1.57% | 23.46B | |
-12.66% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.89% | 17.19B | |
+6.00% | 13.99B | |
+34.93% | 12.53B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Solid Biosciences : Chardan Adjusts Price Target on Solid Biosciences to $17 From $20, Maintains Buy Rating